§ Same category · GLP-1 / metabolic peptides
Survodutide vs Tirzepatide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Survodutide
0
vendors tracked
Tirzepatide
0
vendors tracked
Survodutide
Glucagon/GLP-1 dual agonist
No current listings at 10mg.
Tirzepatide
Dual GLP-1/GIP agonist
No current listings at 10mg.
About Survodutide
A dual glucagon/GLP-1 receptor agonist in clinical trials for obesity and MASH. Research-compound version sold as the free acid.
About Tirzepatide
A once-weekly dual GIP and GLP-1 receptor agonist studied for type-2 diabetes and obesity. Approved clinically in many jurisdictions; research-compound form is widely distributed.